Latest Australian Securities News

Robex Resources Inc reported a substantial net loss for the first half of 2025, reflecting operational challenges and legal settlements, while advancing financing and construction of its key Kiniéro gold project in Guinea.

Nyrada Inc has responded to ASX inquiries confirming the timely and compliant disclosure of positive safety data from its Phase I clinical trial of Xolatryp. The company detailed the timeline of its awareness and release of information, affirming adherence to continuous disclosure rules.

ASX Limited reported a solid FY25 financial performance with a 7.5% rise in underlying net profit and a higher fully franked dividend, while advancing its CHESS replacement project amid ongoing regulatory scrutiny.

ASX Limited reported a robust FY25 with revenue and underlying profit growth, while navigating regulatory scrutiny following a major settlement incident. The company advances its technology transformation and sustainability agenda as it seeks to rebuild trust and deliver shareholder value.

Orezone Gold Corporation reported solid Q2 2025 results with robust earnings and production, while progressing its hard rock expansion projects on schedule. The company’s recent ASX listing and board-approved stage 2 expansion signal a transformative growth phase.

Orezone Gold Corporation reported a robust first half of 2025 with net earnings of $36.7 million and advanced its Bomboré mine expansion, while completing a significant ASX IPO.

Orezone Gold Corporation has successfully completed its initial public offering on the ASX, raising A$75 million to fund expansion at its Bomboré Mine. The company's CHESS Depository Interests started trading under the ticker 'ORE' on August 8, 2025.

Yowie Group Limited has been sanctioned by ASIC for failing to lodge key financial reports, forcing the confectionery company to issue a full prospectus for capital raising until mid-2026. This regulatory setback follows a turbulent period marked by board changes and trading suspensions.

Pinnacle Minerals Limited’s PIMOA securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

AVITA Medical has successfully raised approximately A$23 million through a private placement, positioning the company to advance its therapeutic acute wound care portfolio and target free cash flow by 2026.

Platinum Asia Investments shareholders have decisively approved a scheme to restructure the company by swapping their shares for units in a new ETF, moving the firm closer to a significant transformation pending court approval.

DMC Mining Limited has withdrawn its August 2024 prospectus due to delays in securing exploration licences in Guinea, but remains committed to its critical minerals projects and plans a replacement prospectus once licences are granted.